Agios Pharma(GB:0HB0)
$31.95-0.70 (-2.14%)
GB:0HB0
Agios Pharma financials statements
$31.95
At close:-0.70 (-2.14%)
Agios Pharma (0HB0) Financial Statements
0 Followers
Agios Pharma Financial Overview
Agios Pharma's market cap is currently $1.90B. The company's EPS TTM is $-6.32; its P/E ratio is -5.19; and it has a dividend yield of 1.03%. Agios Pharma is estimated to report earnings on February 25, 2027, and the estimated EPS forecast is $-1.09. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 54.03M | $ 36.50M | $ 26.82M | $ 14.24M | $ 0.00 |
| Gross Profit | $ 42.51M | $ 32.33M | $ 17.32M | $ 12.54M | $ -18.78M |
| Operating Income | $ -472.13M | $ -425.74M | $ -391.49M | $ -389.05M | $ -378.42M |
| EBITDA | $ -408.62M | $ 723.62M | $ -345.46M | $ -223.24M | $ -347.27M |
| Net Income | $ -412.78M | $ 673.73M | $ -352.09M | $ -231.80M | $ 1.60B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 854.42M | $ 893.71M | $ 776.93M | $ 783.12M | $ 1.02B |
| Total Assets | $ 1.30B | $ 1.66B | $ 937.12M | $ 1.24B | $ 1.44B |
| Total Debt | $ 40.21M | $ 56.99M | $ 72.00M | $ 85.66M | $ 97.09M |
| Net Debt | $ -48.92M | $ -19.26M | $ -16.21M | $ -53.60M | $ -106.03M |
| Total Liabilities | $ 104.11M | $ 122.24M | $ 126.10M | $ 137.90M | $ 145.76M |
| Stockholders' Equity | $ 1.19B | $ 1.54B | $ 811.02M | $ 1.10B | $ 1.29B |
| Cash Flow | |||||
| Free Cash Flow | $ -377.29M | $ -391.53M | $ -297.06M | $ -314.36M | $ -413.06M |
| Operating Cash Flow | $ -372.98M | $ -389.84M | $ -296.06M | $ -309.48M | $ -407.32M |
| Investing Cash Flow | $ 377.18M | $ 363.44M | $ 239.57M | $ 243.26M | $ 1.25B |
| Financing Cash Flow | $ 8.68M | $ 14.44M | $ 5.43M | $ 2.35M | $ -765.77M |
Currency in USD
